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2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCCD)
has a long biological half-life in humans (> 7
years) and induces carcinogenicity and severe
developmental, endocrinologic, immunologic,
and reproductive toxicity in animal experi-
ments (Birnbaum and Tuomisto 2000;
Dragan and Schrenk 2000; IARC 1997). The
immune system is one of its most sensitive tar-
gets (Birnbaum and Tuomisto 2000). TCDD
inhibits immunoglobulin secretion and
decreases resistance to bacterial, viral, and para-
sitic infections in exposed animals (Birnbaum
and Tuomisto 2000; Holsapple et al. 1991;
Nohara et al. 2002). In humans, increased
incidence of and mortality from lymphatic
tumors have been found in exposed subjects,
even though there is a lack of consistency
among studies (Bertazzi et al. 2001; IARC
1997). Previous investigations have shown
alterations in humoral immunity, but with no
consistent dose–response relationship and
often with poor control for confounders
(Neubert et al. 2000).
In 1976 an industrial accident contami-
nated a residential area surrounding Seveso,
Italy, with high levels of TCDD. The expo-
sure was acute, relatively pure, and affected
more than 45,000 men, women, and chil-
dren. Measurements of soil levels of TCDD
within 5 weeks delimited three zones (A, B,
and R) of decreasing contamination (Bertazzi
and Di Domenico 1994). Twenty years after
the exposure, TCDD levels were still high in
exposed persons, particularly in women.
Plasma TCDD ranged between 9.8 and 89.9
ppt in individuals from zone A, 1.0–62.6 ppt
in individuals from zone B, and 1.0–18.1
ppt in individuals from the noncontaminated
surrounding area (non-ABR) (Landi et al.
1997, 1998). 
In the present article we report on plasma
immunologic parameters measured about 20
years after the accident in a random sample of
the population of the area. Previous human
studies investigating the effects of TCDD on
humoral immunity are also discussed.
Materials and Methods
Study subjects and laboratory methods. The
selection of subjects, their recruitment, and
their characteristics, as well as dioxin assay
methods, have been described elsewhere
(Landi et al. 1997, 1998). Briefly, we ran-
domly sampled 62 subjects from the most
highly contaminated zones (A and B) and 59
subjects from the surrounding noncontami-
nated area (non-ABR zone). Study subjects
were frequency matched by sex, decade of age,
and cigarette smoking status. Residence in the
speciﬁc zone was veriﬁed at recruitment. We
obtained approvals of the institutional review
boards and written informed consent from
each study subject. A structured questionnaire,
which included the collection of a detailed per-
sonal medical history and medication use in
the week before the study, was administered to
all subjects through personal interview.
We determined internal dose of TCDD
using high-resolution mass spectrometric
analysis performed on human plasma, as
described by Patterson et al. (1987). Eleven
subjects (4 from zone B and 7 from zone non-
ABR) were excluded from the analyses based
on blood TCDD because of missing data.
Standard clinical hematologic and chemistry
assays were performed. We quantiﬁed plasma
immunoglobulins IgA, IgG, and IgM, and
complement components C3 and C4 using
common nephelometric methods (Thomas
1990). We used plasma protein electrophore-
sis to exclude monoclonal immunoglobulins.
One subject from zone non-ABR was
excluded from the study because of missing
immunologic evaluation. We performed all
assays blinded to subject’s exposure status.
Statistical methods. We used nonparamet-
ric tests (Wilcoxon rank-sum, Kruskal-Wallis)
for group comparisons. We performed simple
and multiple regression analyses to assess cor-
relations between variables. Several variables,
such as age, sex, smoking status, body mass
index, consumption of domestic livestock and
poultry, alcohol consumption, acute and
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Articles
Animal studies indicate that the immune system is one of the most sensitive targets of the toxic
effects of 2,3,7,8-tetrachloro-p-dibenzodioxin (TCDD). TCDD inhibits immunoglobulin secre-
tion and decreases resistance to bacterial, viral, and parasitic infections in exposed animals. Nearly
20 years after the Seveso, Italy, accident, we measured immunoglobulin and complement plasma
levels in a random sample of the population in the most highly exposed zones (n = 62) and in the
surrounding noncontaminated area (n = 58). Plasma IgG levels decreased with increasing TCDD
plasma concentration (r = –0.35, p = 0.0002). Median IgG concentration decreased from 1,526
mg/dL in the group with the lowest (< 3.5 ppt) TCDD levels to 1,163 mg/dL in the group with
the highest (20.1–89.9 ppt) TCDD levels (p = 0.002). The association was significant (p =
0.0004) after adjusting for age, sex, smoking, and consumption of domestic livestock and poultry
in multiple regression analysis and persisted after exclusion of subjects with inﬂammatory diseases
and those using antibiotics or nonsteroidal anti-inflammatory drugs. IgM, IgA, C3, and C4
plasma concentrations did not exhibit any consistent association with TCDD levels. We per-
formed a systematic review of all the articles published between 1966 and 2001 on human sub-
jects exposed to TCDD reporting information on circulating levels of immunoglobulins and/or
complement components. The literature indicates that the evidence for effects of TCDD on
humoral immunity is sparse. Methodologic issues, results, and possible sources of variation
between studies are discussed. The possible long-term immunologic effects of TCDD exhibited by
the participants of the present study, coupled with the increased incidence of lymphatic tumors in
the area of the accident, warrant further investigation. Key words: complement, dioxin, environ-
mental disasters, immune system, immunoglobulins, tetrachlorodibenzodioxin. Environ Health
Perspect 110:1169–1173 (2002). [Online 27 September 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p1169-1173baccarelli/abstract.html
RESEARCH
Reviewchronic medical conditions, and current med-
ication use were possible confounding factors.
The variables adjusted for in multiple regres-
sion models were selected on the basis of their
correlation with TCDD and the immunologic
parameters of interest in univariate analysis. All
analyses were performed using the Stata statis-
tical package, Release 7.0 (Stata Corporation,
College Station, TX, USA).
Literature search. To document any pub-
lished association between TCDD and
immunologic parameters, in February 2002
we performed a PubMed (National Library of
Medicine, Bethesda, MD, USA) search of all
studies published from 1966 through
December 2001. The main features of the
studies and results are summarized in Table 1.
We used the search query [“immune system,”
“immunity,” “allergy and immunology,”
“immunocompetence,” “immunologic,”
“immunoglobulins,” “gamma globulins,”
“antibody formation,” “IgA,” “IgM,” “IgG,”
“complement,” “C3,” OR “C4,”] AND
[“TCDD,” “tetrachlorodibenzodioxin,” OR
“dioxins”]. All citations and online abstracts
were examined. We reviewed all the studies on
human subjects exposed to TCDD reporting
information on circulating levels of IgG, IgM,
IgA, and/or complement components. Studies
on subjects exposed to organochlorine com-
pounds that did not include TCDD were not
considered. Details on number of exposed and
nonexposed (control) subjects, sex and mean
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Table 1. Exposure to 2,3,7,8-tetraclorodibenzo-p-dioxin and levels of immunoglobulins and complement components in human subjects. Main features and results
of the studies published between 1966 and December 2001.
Study Subjects Exposure Results
Mean Years from
No.  No. age Acute vs.  ﬁrst exposure  TCDD Control for 
Reference Setting exposed controls Sex (years) Toxicants chronic to the study Assessment internal dose IgG IgM IgA C3 C4 confoundersa
Pocchiari et al. 1979 Seveso, Italy 45 45b M + F 3–7c TCDD Acute ≤ 1.5 Residence, N/A →→ → N/Ad N/Ad No
chloracne
Hoffman et al. 1986 Quail Run  129 139 M + F 27.5 TCDD Chronic 1–14 Residence  N/A → N/A N/A N/A N/A Age, sex, socio-
Park, Missouri, USA history N/A N/A economic level
Jennings et al. 1988 Coalite  18 15 M + F 49.8 TCDD Acute 17 Presence at  N/A →→ → N/A N/A Age, sex, body 
Ltd, UK the accident/ weight, social
clean-up class, alcohol,
smoking
Webb et al. 1989 Missouri, USA 40 — M + F 45.1 TCDD Chronic NR Adipose  ND–750 ppt ↑→→ N/A N/A Age, sex
tissue TCDD
Jansing and Korff 1994Trichlorophenol  8 — NR 49.6 TCDD Chronic 15–28 Blood TCDD 163–1,935 ppt γ-Globulinse N/A N/A No
plant, Germany
Ott et al. 1994 BASF AG,  132 196/42f M 60.7g TCDD Acute 20–39 Work history 1–553 pptg →→ →→→ Sex
Germany 132 — M 60.7 TCDD Acute 20–39 Blood TCDD 1–553 ppt ↑→ ↑→↑ Age, sex, body
mass index,
smoking
Marth et al. 1995 Garbage dumps,  100 98 M 10 PCDDs/PCDFs, Chronic NR Residence NR → N/A → N/A N/A Age, sex
Egypt PAHs, heavy
metals
Løvik et al. 1996 Frierfjord,  24 — M 46h PCDDs/PCDFs Chronic NR Blood NR N/A ↓i N/A N/A N/A Sex
Norway PCDDs/PCDFs
Halperin et al. 1998 NIOSH study  259 243 M 55.7 TCDD Chronic 15–37 Work historyj ND–3,389 pptk ↓j →→↑ j N/A Age, race, sex
subgroup
Jung et al. 1998 Pesticide  187 — Mainly M 56.0h PCDDs/PCDFs Chronic > 10 Blood, serum, 1.2–893 ppt  →→ → N/A N/A Age, smoking
factory, Germany or adipose 
tissue TCDD
Michalek et al. 1999 U.S. Vietnam  894 1,167 M 53.8 TCDD Chronic 16–30 Blood TCDD 0–618 ppt →→ → N/A N/A Age, sex, % body
Veterans fat, race, military
occupation,
alcohol, smoking
Neubert et al. 2000 Boehringer,  88 — Mainly M 36.5 PCDDs/PCDFs Acute NR Blood  1–140 ppt ↓l →→ N/A N/A No
Germany (trial I) PCDDs/PCDFs
Rastatt,  70 — Mainly M 51.5 PCDFs/PCDDs, Chronic > 10 Blood  2–17 ppt  →→ → N/A N/A No
Germany (trial II) lead,  PCDDs/PCDFs
cadmium
Trial I + trial II 158 — Mainly M 43.1 PCDDs/PCDFs, Acute NR for trial I Blood  1–140 ppt →m →→ N/A N/A Age, smoking, ESR, 
lead + PCDDs/PCDFs lymphoocytes/µL
cadmium chronic
Nagayama et al. 2001 Yusho poisoning 69 — M + F 63.4 PCDFs, 
PCBs, 
PCDDs Acute 29 Blood NRn →→ → N/A N/A No
PCDDs/PCDFs,PCBs
Abbreviations: ESR, erythrocyte sedimentation rate; F, female; M, male; N/A, not available; ND, nondetectable; NR, not reported; PAHs, polycyclic chlorinated hydrocarbons; PCBs, poly-
chlorinated biphenyls; PCDDs, polychlorinated dibenzo-p-dioxins; PCDFs, polychlorinated dibenzofurans; ↑, positive association; ↓, negative association; →, no signiﬁcant association
with the exposure.
aMost studies were restricted to males or to a speciﬁc age or were based on a matched design between exposed and nonexposed subjects; few studies used multivariable statistical
models. bNumber of controls not speciﬁed in the article, which summarized the results of periodical assessments of immunologic parameters; according to a later report by Sirchia
(1982), control groups varied at each assessment (average sample size = 45). cAge range. dIn the same study, an increase in total hemolytic complement activity (CH50) was reported by
Sirchia (1982). eNegative association between total γ-globulin concentrations and TCDD blood levels (Spearman rank-correlation: rs = –0.71, p = 0.047, calculated from data reported in
the paper). fImmunoglobulin data from a convenience sample of 196 subjects were provided for comparison; a different referent sample (n = 42) was used for C3 and C4 results. gMean
age and TCDD levels of exposed subjects; blood TCDD was not assayed in controls. hMedian age. iResults not shown, but only summarized in the paper; statistical signiﬁcance was not
reported. jImmune parameters not consistently related to TCDD serum levels after adjusting for age, alcohol, and smoking. kSerum TCDD measured in exposed workers and in 79 control
subjects (< 20 ppt in controls). lNegative association with IgG and IgG1 levels. mOnly results on IgG1 reported. nStudy subjects were divided in three exposure groups according to the
following TCDD toxic equivalent levels: < 70 ppt, 70–200 ppt, ≥ 200 ppt.age of study subjects, characteristics of the
exposure, time from the exposure, final
results, and control for confounders were
retrieved for each study. When the mean age
of all study subjects was not reported, we
computed it using individual age data, if avail-
able. Most articles specified the year of the
beginning (YBE) and of the end (YEE) of the
exposure, and the year of the beginning (YBR)
and of the end (YER) of subjects’ recruitment.
If the time range from the ﬁrst exposure to the
enrollment in the study was not specified in
the article, we derived it as lower limit = YBR
– YEE; upper limit = YER – YBE. When mul-
tiple methods of exposure assessment were
featured in a single study, we reported only
that used in the statistical analysis of immuno-
logic parameters. Study design and statistical
methods were reviewed, and the methods for
confounding prevention or control, such as
matching, restriction, and multivariable
regression analysis (Rothman and Greenland
1998) were ascertained. Immunologic para-
meters were considered associated with
TCDD exposure when statistically signiﬁcant
results (p < 0.05) were reported.
Results
We found a signiﬁcant decrease in IgG levels
(Figure 1) in the exposed subjects. Plasma
IgG ranged from 2,252 to 809 mg/dL and
progressively decreased with increasing lipid-
adjusted TCDD plasma concentration (r =
–0.35, p = 0.0002). The ﬁnding was slightly
more pronounced in female (n = 53, r = –0.39,
p = 0.003) than in male subjects (n = 56, r =
–0.33, p = 0.02). When individuals were
divided in categories of internal dose according
to TCDD quintiles (Table 2), median IgG
concentration decreased from 1,526 mg/dL in
the group with the lowest (<3.5 ppt) TCDD
levels to 1,163 mg/dL in the group with the
highest (20.1–89.9 ppt) TCDD levels (test for
difference between groups, p = 0.002). 
Consistently, subjects from the most con-
taminated zones had lower IgG than subjects
from the surrounding noncontaminated area.
Median IgG levels were 1,403 mg/dL in the
noncontaminated area (non-ABR, n = 58),
1,294 mg/dL in zone B (n = 55; p = 0.03 vs.
non-ABR), and 1,142 mg/dL in zone A, the
most contaminated area (n = 7; p = 0.01 vs.
non-ABR).
We considered several factors that may
have biased the results. We previously showed
that in this population smoking and consump-
tion of domestic livestock and poultry were
among the major determinants of high TCDD
plasma levels, together with female gender and
older age (Landi et al. 1998). In the present
study, median IgG levels were lower in current
(1,202 mg/dL, n = 22) and former (1,281
mg/dL, n = 28) smokers, as compared with
nonsmokers (1,424 mg/dL, n = 59; p = 0.03,
test for difference between groups). Subjects
who reported consumption of domestic live-
stock at the time of the accident (n = 34) had
lower levels of IgG than those who did not
report such consumption (1,228 vs. 1,417
mg/dL, p = 0.06). We used multivariable
regression models to control for these possible
confounding factors. After adjusting for age,
sex, smoking, and consumption of domestic
livestock, the inverse association between
plasma TCDD and IgG remained highly sig-
nificant (p = 0.0004). The results did not
change after exclusion of an outlier subject
who exhibited the lowest IgG levels (r =
–0.32, p = 0.0008 in simple regression analy-
sis, and p = 0.002 after adjusting for age, sex,
smoking, and consumption of domestic live-
stock). Based on clinical chemistry assays and
plasma protein electrophoresis, no subjects
had monoclonal gammopathy, and four had
increased C-reactive protein. No subjects
reported treatment with immunosuppressive
drugs, and five subjects had used antibiotics
in the week before the study. An additional
22 individuals had taken aspirin or other
nonsteroidal anti-inflammatory agents,
mostly for headache, osteoarthritis, or men-
strual pain. We repeated all statistical analyses
excluding each or all the groups (involving a
total of 28 subjects) mentioned above and did
not find any substantial difference in the
results (data not shown).
IgM, IgA, and complement component
C3 plasma concentrations were not signifi-
cantly associated with TCDD levels (Table 2).
Complement component C4 concentrations
were higher in the highest TCDD group
(Table 2) and a positive trend was found in
regression analysis (r = 0.21; p = 0.03). This
association was not signiﬁcant after adjusting
in multivariable regression analysis for age (p =
0.29), or for age, sex, smoking, and consump-
tion of domestic livestock (p = 0.11).
Overall, we retrieved 13 articles that
reported results on immunoglobulin and
complement levels in TCDD-exposed sub-
jects (Table 1). Twelve studies measured
immunoglobulins of one or more immuno-
globulin classes. One article reported total
γ-globulin levels (Jansing and Korff 1994).
Four studies described a decrease in
immunoglobulin levels (Halperin et al. 1998;
Jansing and Korff 1994; Løvik et al. 1996;
Neubert et al. 2000), and two studies reported
increased IgG (Ott et al. 1994; Webb et al.
1989). Complement levels were determined
in three studies, and only one of them
included both C3 and C4 (Ott et al. 1994).
C4 levels, but not C3, were positively associ-
ated with blood TCDD in this study.
Increased total hemolytic complement activity
(CH50) was described in children examined
immediately after the Seveso accident
(Pocchiari et al. 1979; Sirchia 1982). Halperin
et al. (1998) reported increased C3 concentra-
tions in the exposed subjects but no dose–
response relationship with serum TCDD.
Five of the studies reported in Table 1
included subjects exposed not only to TCDD
but also to other polychlorinated dibenzo-
dioxins (PCDDs), polychlorinated dibenzo-
furans (PCDFs), and, in some instances, to
polycyclic chlorinated hydrocarbons (PAHs)
and heavy metals. In other studies carried out
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Figure 1. IgG plasma concentrations and plasma
levels of TCDD in a random population sample of
the highly contaminated zones (A + B) and of the
surrounding noncontaminated area (non-ABR
zone) of Seveso, Italy. Both variables are pre-
sented on a log-scale. r = –0.35; p = 0.0002.
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Table 2. Subjects’ plasma immunoglobulins and complement components by TCDD plasma levels in Seveso, Italy.
Plasma TCDDa
1.2–3.5 ppt (n = 21)  3.6–6.0 ppt (n = 21)  6.1–9.3 ppt (n = 23)  9.4–20.0 ppt (n = 22)  20.1–89.9 ppt (n = 22) 
Interquartile Interquartile Interquartile Interquartile Interquartile
Median rangeb Median rangeb Median rangeb Median rangeb Median rangeb p-Valuec
IgG (mg/dL) 1,526 1,388–1,725 1,422 1,121–1,566 1,363 1,294–1,575 1,302 1,168–1,538 1,163 1,122–1,316 0.002
IgM (mg/dL) 168 126–188 134 107–183 164 92–265 173 112–233 135 86–165 0.42
IgA (mg/dL) 230 191–308 213 157–300 269 201–325 223 193–310 301 167–354 0.66
C3 (mg/dL) 76 67–85 69 61–78 71 63–78 75 64–86 76 61–87 0.64
C4 (mg/dL) 25 20–31 28 21–32 26 22–33 26 20–33 33 26–38 0.04
aPlasma TCDD quintiles were used to deﬁne TCDD categories. b25th–75th percentiles. cKruskal-Wallis test for differences between TCDD categories. in occupational settings, the presence of expo-
sure to other chemicals cannot be ruled out.
The sample size was generally small, with the
exception of two investigations, which
included more than 500 subjects (Halperin et
al. 1998; Michalek et al. 1999). Most studies
were restricted to males or to a speciﬁc age or
were based on a matched design between
exposed and nonexposed subjects. These
methods allow for the control of a limited
number of confounding variables. Five stud-
ies used multivariable statistical models
(Halperin et al. 1998; Jung et al. 1998;
Michalek et al. 1999; Neubert et al. 2000;
Ott et al. 1994), but not all the potential con-
founders were considered in most of them.
Discussion
Nearly 20 years after the Seveso accident, we
found a suppression of IgG plasma levels in
subjects exposed to TCDD. 
Numerous experimental studies showed
that TCDD may suppress both humoral and
cell-mediated immune responses (Birnbaum
and Tuomisto 2000; Kerkvliet 2002).
Inhibition of immunoglobulin secretion has
been demonstrated in multiple animal species
(Birnbaum and Tuomisto 2000; Nohara et
al. 2002; Vorderstrasse et al. 2001), as well as
in human lymphocytes cultivated in vitro
(Sulentic et al. 2000). Zober et al. (1994)
found an increased incidence of infectious
and parasitic diseases in a small retrospective
cohort study of TCDD-exposed workers, but
clinical diagnoses were ill-deﬁned.
The literature indicates that evidence for
TCDD effects on humoral immunity is sparse.
We reviewed all the articles published between
1966 and 2001 on subjects exposed to TCDD
reporting information on circulating levels of
IgG, IgM, IgA, and/or complement compo-
nents (Table 1). Similarly to our findings,
Neubert et al. (2000) reported a decrease in
IgG levels, mainly of the IgG1 subclass, the
most prevalent of human IgG molecules, in
workers exposed to PCDDs and PCDFs in
Germany (Table 1, trial 1). It is suggestive that
the subjects enrolled in this study had blood
TCDD levels similar to those observed in our
study. However, no association was found
between IgG1 and blood toxic equivalent levels
when these results were pooled with a second
group of workers predominantly exposed in a
metal recycling plant to penta- and hexachlori-
nated dibenzofurans, as well as to heavy met-
als, such as lead and cadmium (trial I + II).
Halperin et al. (1998) showed lower mean IgG
levels in 259 male subjects who reported expo-
sure to TCDD during the manufacturing of
2,4,5-trichlorophenate as compared to neigh-
borhood referents. Serum TCDD was mea-
sured in all exposed workers and in only 79 of
the 243 control subjects (TCDD levels were
< 20 ppt in this subsample of control subjects).
When TCDD serum levels were considered,
IgG did not exhibit any consistent trend in a
multivariable model including age, smoking
status, and alcohol consumption. Two addi-
tional small studies, which did not include
IgG measurement, found a decrease in total
γ-globulin (Jansing and Korff 1994) and
serum IgM (Løvik et al. 1996).
In Seveso, an earlier study conducted on
44 children (3–7 years of age, 20 of whom had
chloracne) shortly after the accident exhibited
no change in immunoglobulin concentrations
(Pocchiari et al. 1979). Other reports showed
no alterations in immunoglobulin levels
(Hoffman et al. 1986; Jennings et al. 1988;
Jung et al. 1998; Marth et al. 1995; Michalek
et al. 1999; Nagayama et al. 2001). A slight
positive increase in IgG levels was found in
two studies (Ott et al. 1994; Webb et al.
1989). However, these studies did not exclude
subjects with concurrent medical conditions
likely to increase circulating IgG levels (Ravel
1995). In one of the two investigations, the
authors reported the presence of a subject
affected by liver cancer who had the highest
concentration of TCDD and very high IgG
(Ott et al. 1994). This subject possibly acted
as an outlier in the regression analysis. In the
same study, another subject had liver cirrhosis.
In the second investigation (Webb et al.
1989), 1 of the 12 subjects with high TCDD
levels had hepatomegaly.
As for the complement components, one
investigation showed a positive association
between blood TCDD and C4 (Ott et al.
1994). Increases in C3 (Halperin et al. 1998)
and in CH50 (Sirchia 1982) have been also
reported elsewhere. Similarly, we found a weak
positive association between C4 and TCDD
plasma levels, but the association was not sig-
nificant after adjusting for age and for other
potential confounding factors.
Differences in subject characteristics, time
frame of the studies, as well as in levels, nature,
modality, and assessment of the exposure, may
account for the conflicting results (Table 1)
and certainly limit between-studies compar-
isons, also hindered by the dissimilar and, in
some instances, incomplete presentations of
the results. Our study was conducted on sub-
jects of both sexes and within a wide age range,
who had been acutely exposed to TCDD. In
contrast, most other studies, including the
largest investigation (Michalek et al. 1999)
with 894 U.S. Vietnam veterans exposed to
Agent Orange and 1,167 unexposed individu-
als, which showed no change in immunoglob-
ulin levels, comprised mostly males, with
long-term exposure often to multiple chemical
agents, in occupational (or military) settings.
Due to the type of selection, most subjects
were likely young and/or healthy, and thus not
representative of the general population (Li
and Sung 1999). In the great majority of the
investigations, the small number of subjects
limited the power to detect alterations of the
immunologic parameters.
In earlier studies, the measurement of the
internal dose of TCDD and of other dioxin-
like compounds was estimated by using surro-
gate measures, such as residence or presence in
the contaminated facilities. Kerkvliet (1995)
speculated that subjects with little or no expo-
sure to TCDD might have also been included
in these studies, accounting for the lack of sig-
nificant findings. In our study, results based
on TCDD plasma levels did not differ from
the results based on subjects’ residence in the
exposed areas, but the measurement of indi-
vidual plasma TCDD levels allowed for a
more reﬁned dose–response assessment.
Recently, Neubert et al. (2000) indicated
various factors that can influence immuno-
logic variables and suggested that conclusions
on possible effects of exogenous agents may
be drawn only when all known confounders
are taken into account. The authors provided
a list of possible confounders that included
age, body mass, smoking, alcohol consump-
tion, acute and chronic diseases, and use of
medications. We controlled for all these fac-
tors in our analyses, in contrast to many
investigations listed in Table 2. 
The present study was based on a rela-
tively small random sample of the resident
population of the territory contaminated with
TCDD after the Seveso accident. A similar
number of subjects was drawn from the pop-
ulation of the surrounding noncontaminated
area, which shares the same environmental,
social, educational, and occupational charac-
teristics. A detailed assessment of personal
medical history and medication use was per-
formed and compared with the results of a
selection of standard laboratory tests. 
The clinical signiﬁcance of our ﬁnding is
uncertain. The protective capacity of circu-
lating IgG antibodies against microbial chal-
lenge is well documented (Heinzel 2000).
Children and adult subjects with B-cell-
related primary immunodeficiency syn-
dromes, which exhibit reduced circulating
immunoglobulins, are prone to recurrent
infections and allergic diseases (Heinzel
2000). These subjects are at very high risk
for non-Hodgkin lymphoma (Ziegler 1994)
and increased occurrence of non-Hodgkin
lymphoma has been also reported in TCDD-
exposed subjects (IARC 1997). However,
IgG levels found in our study sample are far
above those typically observed in patients with
antibody immunodeﬁciency disorders (≤ 350
mg/dL) (Heinzel 2000) and only one study
subject had plasma IgG levels below the lower
reference value (< 878 mg/dL) adopted by the
clinical laboratory of the hospital. 
Our finding may reflect a broader alter-
ation of the immune system that more sensitive
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subsets, proliferative responses to mitogens,
and basal and stimulated in vitro cytokine pro-
duction (Colosio et al. 1999) could be assessed
in future studies. In addition, genetic aberra-
tions associated with lymphohemopoietic neo-
plasms (Bäsecke et al. 2002) could be tested.
The results of such studies might have broad
implications for public health, as current back-
ground levels of human exposure to dioxin-like
compounds are close to the recently estab-
lished tolerable daily intake (WHO-ECEH
2000) and thus might be sufficient to elicit
toxic effects on the immune system. 
In conclusion, our study showed a strong
inverse relationship between plasma IgG and
increasing TCDD levels. Plasma TCDD was
not correlated with IgM, IgA, C3, or C4 lev-
els. The possible long-term immunologic
effects of TCDD, coupled with the increased
incidence of lymphatic tumors in the area of
the accident (Bertazzi et al. 2001) and the
conflicting results in the literature warrant
further investigation.
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